Get the App
A

An2 Therapeutics (ANTX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About An2 Therapeutics (ANTX)

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The Company is focused on advancing its first product candidate, epetraborole, a once... Read more

  • USD10.05
  • USD10.05
  • USD9.58
  • USD23.58
  • -16.10%
  • --
  • 12.30k
  • 33.45k
  • 201M
  • 6.88
  • -38.50%

Stock News

Market Extra: Assets in money-market funds touch new $5.2 trillion record, ICI says

yesterday

Market Extra: Assets in money-market funds touch new $5.2 trillion record, ICI says

MarketWatch

The Conversation: Trump indictment won’t keep him from presidential race, but will make his reelection bid much harder

yesterday

The Conversation: Trump indictment won’t keep him from presidential race, but will make his reelection bid much harder

MarketWatch

: Virgin Orbit stock plunges after report says company will cease operations

yesterday

: Virgin Orbit stock plunges after report says company will cease operations

MarketWatch

: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged

yesterday

: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged

MarketWatch

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium